Investigating its oncogenic propensity, Xie, Li et al. uncovered that suppressing TRIM26 leads to the inhibition of proliferation, migration, and invasion of bladder cancer cells by impeding the AKT/GSK3b/b-catenin pathway(4). This evidence concerns the gene TRIM26 and urinary bladder cancer.